Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Oncology (Williston Park, N.Y.)|March 17, 2018
Managing Nausea and Vomiting in Patients With Cancer: What WorksRudolph M NavariExpert Opinion on Pharmacotherapy|March 17, 2009
Antiemetic control: toward a new standard of care for emetogenic chemotherapyRudolph M NavariExpert Opinion on Drug Metabolism & Toxicology|November 26, 2009
Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonistRudolph M NavariCurrent Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activitiesRudolph M NavariEuropean Journal of Pharmacology|October 26, 2013
Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomitingRudolph M NavariExpert Opinion on Drug Safety|October 18, 2019
The safety of rolapitant for the treatment of nausea and vomiting associated with chemotherapyRudolph M NavariCancer Management and Research|December 29, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacyRudolph M NavariFuture Oncology (London, England)|July 14, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancerRudolph M NavariJournal of the National Comprehensive Cancer Network : JNCCN|January 24, 2007
Prevention of emesis from multiple-day and high-dose chemotherapy regimensRudolph M NavariCurrent Treatment Options in Oncology|February 7, 2020
Nausea and Vomiting in Advanced CancerRudolph M NavariPageof 8